News Chart Medivir AB Deutsche Boerse AG

Equities

MVR0

SE0020181014

Delayed Deutsche Boerse AG Other stock markets 08:57:50 17/07/2024 BST			5-day change	1st Jan Change
0.22 ^EUR	-3.51%		-11.65%	+0.55%

06-27	Medivir AB Presents Positive New Data from Its Ongoing Phase Ib / IIa Study of Fostroxacitabine Bralpamide + Lenvima® in Advanced Hepatocellular Carcinoma	CI
06-20	Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 20-JUN-2024.	CI

a30596f0abbaa7e085bf6d0ee1bd73.XcPRGpWJ5T75zbrPF2UE0fLOHts1R0HJ_RhIx9Yy7sE.Co-ZQP_asQiyoPShUz115KWLW7ZXDy6ItVEu8Z1ghbUXt-hc5cSSV4j5gg~b2e9a13b75483e9174cd1d5c9ed0b309